What is DMEK?
Descemet’s membrane endothelial keratoplasty (DMEK) is the latest and most advanced option available to treat damaged corneas associated with Fuchs’ Dystrophy and other causes of poor corneal endothelial function. Like DSEK and DSAEK, DMEK is a corneal transplant procedure that replaces only the innermost portion of the cornea, rather than the full thickness of the cornea as in traditional corneal transplants (PKP).
Compared to traditional PKP, DSEK, and DSAEK options, DMEK is the most anatomically friendly repair possible – utilizing just one cell layer and a thin membrane, all of which is only 15 to 20 microns thick (less than 1/5 the thickness of a human hair).
DMEK leaves the patient’s cornea closer to its original condition than any other transplant technique. DMEK has been shown to offer patients the best chance of achieving 20/25 or better vision, resuming normal activities quickly, and avoiding vision-threatening rejection episodes.
DMEK has provided such a significant improvement in vision with a reduced risk of rejection that we are now advising many patients to have their two eyes affected by Fuchs’ disease operated on 1-2 weeks apart, with or without cataract surgery.


